HaystackMRD
Healthcare Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
301 W 29th St Ste 2004U, Baltimore, Mary...Phone Number
(410) 297-1000Website
www.haystackmrd.comRevenue
$6.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
1
2
1
1
About HaystackMRD
Founded in 2021 and headquartered in Baltimore, Maryland, Haystack Oncology is a cancer treatment and therapy monitoring company.Explore more
HaystackMRD Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is HaystackMRD your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when HaystackMRD launches new products
Check if HaystackMRD has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on HaystackMRD recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
HaystackMRD, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at HaystackMRD
Click to see if HaystackMRD had a recent Job posting/layoffs
Funding: Get notified immidiatlly once HaystackMRD has new funding data
Check out if HaystackMRD is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined HaystackMRD as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
HaystackMRD is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
HaystackMRD is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about HaystackMRD.
HaystackMRD financials insights
Gather financial insights about HaystackMRD, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$56M
HaystackMRD Tech Stack
A closer look at the technologies used by HaystackMRD
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Event
Product Marketing, Events, Research & Development, Bioengineering, Medical Research, Clinical Operations, Healthcare Technology
Mergers & Acquisitions (M&A)
Award
Award
New Hire
Executive Move
HaystackMRD News & Media
Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing
Achieving the rigorous laboratory standard broadens access for providers and patients in New York; applies to use of Haystack MRD for patients with solid tumor cancers SECAUCUS, N.J., June 24, 2026 /PRNewswire/ -- Quest Diagnostics® (NYSE: DGX), a leading provider of diagnostic...City of Hope to Evaluate Quest Diagnostics' Haystack MRD® for Guiding Patient Management in Multiple Cancers
Fourteen City of Hope sites across the U.S. participating in research using the Haystack MRD ctDNA Test in patients with breast, colorectal, ovarian, and prostate cancer SECAUCUS, N.J. and LOS ANGELES, April 16, 2026 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of...MVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD® Technology from Quest Diagnostics®
Blood test to aid cancer treatment and recurrence monitoring now available from a German lab for potentially faster results HAMBURG, Germany, Oct. 17, 2025 /PRNewswire/ -- MVZ HPH Institute for Pathology and Hematopathology GmbH, today announced the availability of HPH MRD, a new...FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
SECAUCUS, N.J., Aug. 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the company's Haystack MRD® test for...
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding HaystackMRD
Sign Up For FreeTo access detailed company insights
Founded in 2021 and headquartered in Baltimore, Maryland, Haystack Oncology is a cancer treatment and therapy monitoring company.... Read More
